课题基金 / 基金详情

A Randomized Controlled Trial Testing the Efficacy of an Insulin-Dose Learning Algorithm in Adults with Type 1 Diabetes

A Randomized Controlled Trial Testing the Efficacy of an Insulin-Dose Learning Algorithm in Adults with Type 1 Diabetes
一项测试胰岛素剂量学习算法对成人 1 型糖尿病患者疗效的随机对照试验
批准号：
428886
负责人：
Kobayati Alessandra
金额：
$1.27万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-12-01 至 2020-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=428886&lang=en
关键词：
Clinical Research Enhanced Treatment Technology For Type 1 Diabetes Glucose Control Glucose Sensor Technology Insulin Intensive Therapy Multiple Daily Injections Personalized Learning Algorithm Randomized Controlled Trial Smart Insulin Pens Type

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"Type 1 diabetes (T1D) is a metabolic disease that results in no insulin production from the pancreas, a hormone required to allow glucose to be used as energy. Despite advances in diabetic treatment technology, maintaining glucose targets is difficult to
期刊论文(0)
专著(0)
科研奖励(0)
会议论文